Skip to main content
European Commission logo print header

The European Mouse Genome Mutagenesis Program

Objectif

The EUCOMM integrated project responds to the priority topic defined by Priority 1. Life Sciences and Biotechnology for Health, 'Genome-wide Mutagenesis in Mouse'. EUCOMM integrates European skills, efforts, resources, and infrastructure to produce, in a systematic high throughput way, mutations throughout the mouse genome. A collection of up to 20.000 mutated genes will be generated in mouse embryonic stem (ES) cells using conditional gene trapping and gene targeting approaches. This library will enable mouse mutants to be established worldwide in a standardized and cost-effective manner, making mouse mutants available to a much wider biomedical research community than has been possible previously. For a subset of genes relevant for human disease, mutant mice will be established, archived and analyzed. This will offer an opportunity to decipher molecular disease mechanisms and in some cases provide a foundation for the development of diagnostic, prognostic and therapeutic strategies. This project is built on exceptionally strong European expertise in mouse molecular genetics, genomics and bioinformatics and will enable automation of targeting vector production and professional dissemination of material. EUCOMM will foster integration with existing European consortia which address mouse gene expression analysis, mutant phenotyping, imaging and archiving. Progress of all of these projects will be enhanced by EUCOMM mouse mutants. All targeting vectors, mutant ES cells, mouse resources, and Standard Operating Procedures generated by EUCOMM will be displayed to the scientific community via the EUCOMM web linked database, other EU consortia databases and the Ensembl browser, and distributed professionally. Taken together, EUCOMM will make a major contribution to the analysis of gene function. Finally, EUCOMM resources represent major opportunities for exploitation by SMEs and the pharmaceutical industry.

Appel à propositions

FP6-2004-LIFESCIHEALTH-5
Voir d’autres projets de cet appel

Régime de financement

IP - Integrated Project

Coordinateur

HELMHOLTZ ZENTRUM MÜNCHEN
Contribution de l’UE
Aucune donnée
Adresse
Ingolstaedter Landstrasse 1
NEUHERBERG
Allemagne

Voir sur la carte

Liens
Coût total
Aucune donnée

Participants (10)